HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 494 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $11,709,576 | -41.2% | 113,851 | -37.7% | 0.00% | -50.0% |
| Q1 2023 | $19,929,510 | -82.2% | 182,605 | -81.4% | 0.00% | -81.8% |
| Q4 2022 | $111,948,930 | -31.5% | 983,734 | -62.7% | 0.02% | -37.1% |
| Q3 2022 | $163,443,000 | +76.0% | 2,640,849 | +126.8% | 0.04% | +84.2% |
| Q2 2022 | $92,870,000 | +53.0% | 1,164,358 | +101.8% | 0.02% | +90.0% |
| Q1 2022 | $60,715,000 | +66.1% | 577,079 | +70.1% | 0.01% | +66.7% |
| Q4 2021 | $36,555,000 | -1.6% | 339,230 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $37,159,000 | -36.0% | 339,230 | -45.3% | 0.01% | -40.0% |
| Q2 2021 | $58,031,000 | -24.9% | 619,721 | -26.2% | 0.01% | -28.6% |
| Q1 2021 | $77,302,000 | +25.4% | 839,870 | -0.4% | 0.01% | +27.3% |
| Q4 2020 | $61,663,000 | +52.0% | 842,961 | +61.4% | 0.01% | +37.5% |
| Q3 2020 | $40,580,000 | +18262.0% | 522,392 | +6338.2% | 0.01% | – |
| Q3 2019 | $221,000 | -14.7% | 8,114 | -24.6% | 0.00% | – |
| Q2 2019 | $259,000 | – | 10,764 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |